Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells.
van Wetering. Sandra S; Tjabringa. G Sandra GS; Hiemstra. Pieter S PS
Key Findings
- LL-37 stimulates airway epithelial cells to produce inflammatory mediators
- It promotes chemotaxis (movement) of immune cells toward the airway lining
- It can enhance proliferation and wound‑repair processes in airway tissue
Practical Outcomes
- The main takeaway is that LL-37 has immune‑modulating and tissue‑repair roles in the lungs, which may be relevant for respiratory health. However, the review offers no concrete dosage or supplementation guidance, so biohackers should treat it as background knowledge rather than a ready‑to‑use protocol.
Summary
LL-37, a natural peptide made by white blood cells, can talk to the cells lining your airways. It can boost the release of signaling molecules, attract other immune cells, and help those airway cells grow and heal. The paper reviews these effects but doesn’t give dosing tips or new ways to use the peptide for health hacks.
Abstract
Most antimicrobial peptides have been discovered based on activity-guided purification procedures, which used assays to determine their antimicrobial activity. Nevertheless, recent studies have shown that antimicrobial peptides also exert a range of other functions. Based on these observations, antimicrobial peptides are now not only implicated in host defense against infection but also in other immune reactions, inflammation, and wound-repair processes. The activities of neutrophil defensins and the cathelicidin hCAP-18/LL-37, antimicrobial peptides that are abundantly expressed in the human neutrophil, are the subject of an increasing number of studies. Exposure to neutrophil defensins and hCAP-18/LL-37 results in increases in mediator expression and release, chemotaxis, and proliferation of inflammatory and epithelial cells and fibroblasts, and the mechanisms underlying these effects have been partly elucidated. This review is focused on the effects of neutrophil defensins and hCAP-18/LL-37 on airway epithelial cells.
Study Information
pubmed
2004
2004-12-09T00:00:00.000Z
10.1189/jlb.0604367
59
77